8/1/2025, 4:30:39 AM | www.ainvest.com | news
Exponent's Q2 2025: Navigating Contradictions in Regulatory Impact, Growth Expectations, and Demand Dynamics
Exponent reported flat revenues in Q2 2025, driven by disciplined execution and resilience amid dynamic market conditions. Growth in dispute-related activities across construction, automotive, and medical device sectors, along with proactive utility risk management, offset softer demand in chemical regulatory work. EBITDA declined 7% to $37 million due to lower utilization, increased operating expenses, and reduced miscellaneous income. Reactive engagements (litigation-related) grew 7% YoY, while proactive risk management in the utility sector showed similar growth.